Additionally, studies on the potential role of ATP7B in colorectal and ovarian cancer have confirmed that its overexpression is tied to a poor response to platinum treatment [152, 153], but not in urinary bladder cancer patients, calling for further needed research to be conducted. Here, ATP7B is linked to urinary bladder cancer.